-
11 May 2022
-
10 May 2022
-
'Interventions to reduce the risk of coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) infection among workers outside healthcare settings'
What is the aim of this review?
Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS‐CoV‐2 (severe acute respiratory syndrome...
9 May 2022
-
9 May 2022
-
Dear Friends and Colleagues
Due to the continued global impact of COVID-19 (coronavirus) with ongoing reduced/restricted travel from many regions, and the advent of geo-political instability and risks in the European region, we have taken the decision to postpone the Global Evidence Summit (GES 2), due to be hosted in Prague between 2 – 6 October...
4 May 2022
-
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have...
2 May 2022
-
27 4月 2022
-
25 4月 2022
-
Cochrane wants to welcome people, no matter who they are or where they live. The more varied perspectives we have, the better we can provide evidence to help inform health and healthcare decisions.
In October 2021, we launched our listening and learning exercise that aimed to gather data, views and experiences regarding diversity and...
25 4月 2022
-
11 4月 2022
-
New Cochrane Review: Control interventions in randomised trials for people with a mental health disorder
KEY MESSAGES
Researchers use many different control interventions in randomized trials on treatments for patients with mental health disorders, but there is little consensus on how to report and adequately design these controls. This practice...
8 4月 2022
-
Cochrane’s Governing Board is pleased to announce the appointment of Catherine Spencer as Cochrane’s new Chief Executive Officer.
Catherine joins Cochrane from The Seafarers’ Charity where she held the position of CEO.
Prior to her role at The Seafarers’ Charity, Catherine was acting Chief Operating Officer and Director of Communications and...
7 4月 2022
-
Grant to enhance evidence-informed guideline recommendations for newborn and young child health in South Africa, Malawi and Nigeria
The Global Evidence, Local Adaptation project aims to maximise the impact of evidence for poverty-related diseases by increasing the capacity of decision makers and researchers to use global research to develop...
6 4月 2022
-
The World Health Organization (WHO) has issued an updated postnatal guideline which is supported by evidence from Cochrane Pregnancy and Childbirth reviews and one Cochrane Incontinence review.
Cochrane has been a non-governmental organization in official relations with WHO since 2011, and a major aspect of this partnership is supporting WHO’s...
30 3月 2022
-
A new Cochrane Library editorial has published 'Protecting human health in a time of climate change: how Cochrane should respond.'
Researchers and methodologists have an important contribution to make to the response to climate change, by producing and synthesizing evidence relevant to climate-health impacts. While Cochrane has identified climate...
30 3月 2022
-
29 3月 2022
-
Cochrane US and Lifeology hosted an International Women's Day themed #sciart challenge. The two winning designs have been selected and added to the Cochrane Store.
For International Women’s Day (IWD) on March 8th, Cochrane hosted several free events, including an art and graphic challenge with Cochrane US and Lifeology to illustrate...
25 3月 2022
-
With the new feature of including PICO terms on review pages, you will be able to find the most relevant Cochrane evidence to answer your research or clinical question.
One way to construct a well-built question is to use the PICO model. PICO stands for Population, Intervention, Comparison, and Outcomes.
Population (or Patient or Problem) What...
16 3月 2022
-
15 3月 2022
-
14 3月 2022
11 May 2022
10 May 2022
'Interventions to reduce the risk of coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) infection among workers outside healthcare settings' What is the aim of this review? Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS‐CoV‐2 (severe acute respiratory syndrome...9 May 2022
9 May 2022
Dear Friends and Colleagues Due to the continued global impact of COVID-19 (coronavirus) with ongoing reduced/restricted travel from many regions, and the advent of geo-political instability and risks in the European region, we have taken the decision to postpone the Global Evidence Summit (GES 2), due to be hosted in Prague between 2 – 6 October...4 May 2022
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have...2 May 2022
27 4月 2022
25 4月 2022
Cochrane wants to welcome people, no matter who they are or where they live. The more varied perspectives we have, the better we can provide evidence to help inform health and healthcare decisions.
11 4月 2022
New Cochrane Review: Control interventions in randomised trials for people with a mental health disorder KEY MESSAGES Researchers use many different control interventions in randomized trials on treatments for patients with mental health disorders, but there is little consensus on how to report and adequately design these controls. This practice...8 4月 2022
Cochrane’s Governing Board is pleased to announce the appointment of Catherine Spencer as Cochrane’s new Chief Executive Officer. Catherine joins Cochrane from The Seafarers’ Charity where she held the position of CEO. Prior to her role at The Seafarers’ Charity, Catherine was acting Chief Operating Officer and Director of Communications and...7 4月 2022
Grant to enhance evidence-informed guideline recommendations for newborn and young child health in South Africa, Malawi and Nigeria The Global Evidence, Local Adaptation project aims to maximise the impact of evidence for poverty-related diseases by increasing the capacity of decision makers and researchers to use global research to develop...6 4月 2022
The World Health Organization (WHO) has issued an updated postnatal guideline which is supported by evidence from Cochrane Pregnancy and Childbirth reviews and one Cochrane Incontinence review. Cochrane has been a non-governmental organization in official relations with WHO since 2011, and a major aspect of this partnership is supporting WHO’s...30 3月 2022
A new Cochrane Library editorial has published 'Protecting human health in a time of climate change: how Cochrane should respond.' Researchers and methodologists have an important contribution to make to the response to climate change, by producing and synthesizing evidence relevant to climate-health impacts. While Cochrane has identified climate...30 3月 2022
29 3月 2022
Cochrane US and Lifeology hosted an International Women's Day themed #sciart challenge. The two winning designs have been selected and added to the Cochrane Store.
Find exactly the evidence you need: at-a-glance PICO summaries now available with Cochrane AbstractsWith the new feature of including PICO terms on review pages, you will be able to find the most relevant Cochrane evidence to answer your research or clinical question. One way to construct a well-built question is to use the PICO model. PICO stands for Population, Intervention, Comparison, and Outcomes. Population (or Patient or Problem) What...16 3月 2022
15 3月 2022
14 3月 2022